Today: January 16, 2019, 6:49 am
  
Business

Sparrho Appoints Basil Moftah, MBA, as Chairman of the Board of Directors

PR-Inside.com: 2018-11-08 16:08:02

The veteran IP and investments expert will lead Sparrho as they expand and accelerate their innovation of scientific communications and pharmaceuticals strategies

Sparrho Appoints Basil Moftah, MBA, as Chairman of the Board of Directors

Sparrho
Courtney Glymph
Courtney@sparrho.com
07867488769

Sparrho, the leading company for the integration of artificial intelligence in scientific research and communication, today announced the appointment of Basil Moftah, MBA, as chairman of its board of directors.

Basil attained his MBA from the prestigious Harvard Business School and will bring two decades of experience as a senior executive working for Thomson Reuters’ Intellectual Property and Science department, managing over $1 billion in revenue and almost 4000 employees globally to deliver the latest scientific developments and support services for high-level clients including governments, academic institutions and leading businesses.

Since leaving Thomson Reuters in 2015, Basil has championed new ventures, such as the digital patent storage platform PatSnap, and the intelligent product builder TARA.AI. He has also been an investor in Sparrho since 2016, and so is perfectly placed to spur on the rapid expansion of the company, utilising his intimate knowledge of cutting-edge developments in the scientific and tech sectors.

While at Thomson Reuters, Basil chaired and supported various diversity and inclusion programs, including a role as Corporate Sponsor of Thomson Reuters Leadership Program for Women – a promising sign in an industry vastly underrepresented by women. He has also worked across all emerging markets, and this international outlook will set Sparrho in good stead to expand their operations throughout Asia.

The appointment of Basil comes as the scientific community faces a crossroads. Sparrho sits at the nucleus of the intersection between science and technology, creating a platform that seeks to further provide accessibility and accountability across industry and geography. Sparrho’s powerful platform, using analytics and AI, reimagines the possibility of a new, improved and democratised scientific ecosystem.

Basil says of his new appointment: “This is an exciting time to join the Sparrho Board. The company plays a crucial and unique role in driving the aggregation, curation, and summarisation of cutting-edge research. I am delighted to be joining such a dynamic team who are the only global players capable of democratising access to science for all.”

CEO of Sparrho, Vivian Chan, says, “We are delighted to have Basil join our close-knit and dedicated team at Sparrho. His vast expertise and continued enthusiasm for our work will be invaluable in carrying us forward as the disruptive company simplifying science for researchers and brands. We’re all excited to see what the future holds!”

-ENDS-

Follow Sparrho

Sparrho on Medium

Join the Twitter Conversation

Join us on LinkedIn

About Sparrho

Sparrho democratises scientific knowledge, making it more accessible, searchable and shareable. A blend of machine learning and expert curation ensures you automatically stay on top of the science that matters to you. Sparrho has attracted over one million users from more than 150 countries who search over 60 million pieces of content every day, making it the leading platform for the discovery, curation, and dissemination of scientific research.

News! @Sparrho welcomes Basil Moftah, MBA, as chairman of the Board of Directors #UKTech #Science #AI #TechNews https://bit.ly/2D9aLLC

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
http://www.pr-inside.com/


# 674 Words
Related Articles
More From The Author
Notice on the convened Extraordinary General Meeting [..]
We hereby inform you that on the initiative and by the decision of the Board of AB Klaipėdos Nafta, legal [..]
Medtronic Begins Renal Denervation Study for High [..]
FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat [..]
Banca IFIS: margins and customers up for [..]
Banca IFIS: margins and customers up for the 9 months. Rising profitability and strong cash flow generation in the NPL [..]
Urban Airship Receives Highest Product Scores in [..]
Gartner's companion Critical Capabilities report provides deeper insight into product offerings included in 2018 Gartner Magic [..]
From Global Times: Djibouti denies being ‘induced’ [..]
Loans from China ‘shape Djibouti’s economic development’ BEIJING, Nov. 08, 2018 (GLOBE NEWSWIRE) -- A senior Djibouti government [..]
 
More From Business
The Executive Talk: Chememan PCL (SET:CMAN)
BANGKOK, Jan 15, 2019 - (ACN Newswire) - Chememan PCL (SET:CMAN) Chief Executive Officer, Mr. Adisak Lowjun discusses the company's [..]
Sapphire's Subsidiary Awarded EPC Contract of RMB [..]
SINGAPORE, Jan 15, 2019 - (ACN Newswire) - SGX Mainboard-listed Sapphire Corporation Limited ("Sapphire", and together [..]
Hong Kong Investment Promotion chief visits London [..]
HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative [..]
Wildfire Design & Build Receives 2018 Best [..]
NAPA December 13, 2018 -- Wildfire Design & Build has been selected for the 2018 Best of Napa Award in [..]
Discover an Excellent Guide, Dedicated to Beauty [..]
03 January 2019 – The Youthist provides a plethora of useful recommendations to those readers, who want to look young [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.